Analytical and Clinical Performance of the Nanopia Krebs von den Lungen 6 Assay in Korean Patients With Interstitial Lung Diseases.

Eun Jung ChoKyoung Jin ParkDae Hyun KoHyun Jung KooSang Min LeeJin Woo SongWoochang LeeHae Kyung LeeKyung Hyun DoSail ChunWon-Ki Min

Published in: Annals of laboratory medicine (2019)

The overall analytical and clinical performance of the Nanopia KL-6 assay was acceptable. Our study is the first to compare assay platforms and show correlations between KL-6 concentrations and HRCT or PFT results in Korean ILD patients.

Keyphrases

high throughput
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
interstitial lung disease
single cell
mass spectrometry